Loading...

Azure Healthcare

ASX:AZV
Snowflake Description

Flawless balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AZV
ASX
A$16M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

Azure Healthcare Limited, together with its subsidiaries, manufactures, services, supplies, and distributes healthcare and electronic communications equipment in Australia, New Zealand, Asia, Europe, and North America. The last earnings update was 56 days ago. More info.


Add to Portfolio Compare Print
  • Azure Healthcare has significant price volatility in the past 3 months.
AZV Share Price and Events
7 Day Returns
7.7%
ASX:AZV
3.2%
AU Medical Equipment
-0%
AU Market
1 Year Returns
-14.6%
ASX:AZV
-2.2%
AU Medical Equipment
4.6%
AU Market
AZV Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Azure Healthcare (AZV) 7.7% 27.3% 11.1% -14.6% -1.4% -80.8%
AU Medical Equipment 3.2% -0.5% 0.8% -2.2% 38.7% 105%
AU Market -0% 1% 6.9% 4.6% 18.2% 4.8%
1 Year Return vs Industry and Market
  • AZV underperformed the Medical Equipment industry which returned -2.2% over the past year.
  • AZV underperformed the Market in Australia which returned 4.6% over the past year.
Price Volatility
AZV
Industry
5yr Volatility vs Market

Value

 Is Azure Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Azure Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Azure Healthcare.

ASX:AZV Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year AU Government Bond Rate 2.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ASX:AZV
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AU Govt Bond Rate 2.3%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.928 (1 + (1- 30%) (2.54%))
0.963
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.96
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.31% + (0.963 * 5.96%)
8.05%

Discounted Cash Flow Calculation for ASX:AZV using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Azure Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

ASX:AZV DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 8.05%)
2019 3.41 Est @ 105.64% 3.16
2020 5.96 Est @ 74.64% 5.10
2021 9.11 Est @ 52.94% 7.22
2022 12.55 Est @ 37.75% 9.21
2023 15.95 Est @ 27.12% 10.83
2024 19.09 Est @ 19.68% 12.00
2025 21.85 Est @ 14.47% 12.71
2026 24.22 Est @ 10.82% 13.03
2027 26.22 Est @ 8.27% 13.06
2028 27.92 Est @ 6.48% 12.87
Present value of next 10 years cash flows A$99.18
ASX:AZV DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$27.92 × (1 + 2.31%) ÷ (8.05% – 2.31%)
A$497.69
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$497.69 ÷ (1 + 8.05%)10
A$229.44
ASX:AZV Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$99.18 + A$229.44
A$328.62
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$328.62 / 232.71
A$1.41
ASX:AZV Discount to Share Price
Calculation Result
Value per share (AUD) From above. A$1.41
Current discount Discount to share price of A$0.07
= -1 x (A$0.07 - A$1.41) / A$1.41
95%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Azure Healthcare is available for.
Intrinsic value
>50%
Share price is A$0.07 vs Future cash flow value of A$1.41
Current Discount Checks
For Azure Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Azure Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Azure Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Azure Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Azure Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:AZV PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$0.00
ASX:AZV Share Price ** ASX (2019-04-23) in AUD A$0.07
Australia Medical Equipment Industry PE Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 33.38x
Australia Market PE Ratio Median Figure of 544 Publicly-Listed Companies 16.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Azure Healthcare.

ASX:AZV PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:AZV Share Price ÷ EPS (both in AUD)

= 0.07 ÷ 0.00

56.09x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Azure Healthcare is overvalued based on earnings compared to the AU Medical Equipment industry average.
  • Azure Healthcare is overvalued based on earnings compared to the Australia market.
Price based on expected Growth
Does Azure Healthcare's expected growth come at a high price?
Raw Data
ASX:AZV PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 56.09x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Oceania Medical Equipment Industry PEG Ratio Median Figure of 5 Publicly-Listed Medical Equipment Companies 2.62x
Australia Market PEG Ratio Median Figure of 360 Publicly-Listed Companies 1.35x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Azure Healthcare, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Azure Healthcare's assets?
Raw Data
ASX:AZV PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$0.04
ASX:AZV Share Price * ASX (2019-04-23) in AUD A$0.07
Australia Medical Equipment Industry PB Ratio Median Figure of 30 Publicly-Listed Medical Equipment Companies 2.72x
Australia Market PB Ratio Median Figure of 1,676 Publicly-Listed Companies 1.67x
ASX:AZV PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:AZV Share Price ÷ Book Value per Share (both in AUD)

= 0.07 ÷ 0.04

1.73x

* Primary Listing of Azure Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Azure Healthcare is good value based on assets compared to the AU Medical Equipment industry average.
X
Value checks
We assess Azure Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Azure Healthcare has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Azure Healthcare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Azure Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.2%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Azure Healthcare expected to grow at an attractive rate?
  • Unable to compare Azure Healthcare's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Azure Healthcare's earnings growth to the Australia market average as no estimate data is available.
  • Unable to compare Azure Healthcare's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:AZV Future Growth Rates Data Sources
Data Point Source Value (per year)
Australia Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 13.2%
Australia Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.4%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.7%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:AZV Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:AZV Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 30 2 0
2018-09-30 29 2 1
2018-06-30 29 2 1
2018-03-31 30 1 0
2017-12-31 30 1 -1
2017-09-30 30 -1 -4
2017-06-30 29 -3 -6
2017-03-31 28 -4 -7
2016-12-31 27 -5 -8
2016-09-30 29 -3 -6
2016-06-30 32 -2 -4
2016-03-31 32 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Azure Healthcare is high growth as no earnings estimate data is available.
  • Unable to determine if Azure Healthcare is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:AZV Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Azure Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:AZV Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 0.00
2018-09-30 0.00
2018-06-30 0.01
2018-03-31 0.00
2017-12-31 -0.01
2017-09-30 -0.02
2017-06-30 -0.03
2017-03-31 -0.03
2016-12-31 -0.04
2016-09-30 -0.03
2016-06-30 -0.02
2016-03-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Azure Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Azure Healthcare is trading at Azure Healthcare'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Azure Healthcare's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Azure Healthcare's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Azure Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Azure Healthcare has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Azure Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Azure Healthcare's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Azure Healthcare's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • Azure Healthcare has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Azure Healthcare has become profitable in the last year making it difficult to compare the AU Medical Equipment industry average.
Earnings and Revenue History
Azure Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Azure Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:AZV Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 29.67 0.29 11.45
2018-09-30 29.31 0.74 11.33
2018-06-30 28.94 1.19 11.21
2018-03-31 29.52 -0.12 11.64
2017-12-31 30.11 -1.43 12.07
2017-09-30 29.51 -3.92 12.58
2017-06-30 28.92 -6.42 13.10
2017-03-31 28.12 -7.06 13.68
2016-12-31 27.31 -7.71 14.27
2016-09-30 29.44 -5.68 14.97
2016-06-30 31.57 -3.65 15.67
2016-03-31 31.68 -1.98 15.89
2015-12-31 33.24 -0.30 16.11
2015-09-30 33.37 0.39 15.71
2015-06-30 33.50 1.08 15.31
2014-12-31 32.83 2.57 13.92
2014-09-30 32.07 3.21 13.24
2014-06-30 31.31 3.85 12.56
2013-12-31 27.21 2.57 11.32
2013-09-30 24.84 1.77 10.38
2013-06-30 22.48 0.97 9.43
2013-03-31 21.61 0.91 8.91
2012-12-31 20.74 0.86 8.25
2012-09-30 19.48 0.61 8.06
2012-06-30 18.22 0.37 7.86

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Azure Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Azure Healthcare used its assets less efficiently than the AU Medical Equipment industry average last year based on Return on Assets.
  • Azure Healthcare has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
X
Past performance checks
We assess Azure Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Azure Healthcare has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Azure Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Azure Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Azure Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Azure Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Azure Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 39.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Azure Healthcare Company Filings, last reported 3 months ago.

ASX:AZV Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 9.43 0.41 2.01
2018-09-30 9.43 0.41 2.01
2018-06-30 9.58 0.66 2.31
2018-03-31 9.58 0.66 2.31
2017-12-31 8.57 0.91 1.88
2017-09-30 8.57 0.91 1.88
2017-06-30 8.26 1.15 1.72
2017-03-31 8.26 1.15 1.72
2016-12-31 9.53 1.96 1.52
2016-09-30 9.53 1.96 1.52
2016-06-30 12.17 2.03 1.69
2016-03-31 12.17 2.03 1.69
2015-12-31 15.26 2.06 1.91
2015-09-30 15.26 2.06 1.91
2015-06-30 15.54 1.34 3.16
2014-12-31 15.34 1.32 3.11
2014-09-30 15.34 1.32 3.11
2014-06-30 14.37 1.33 1.61
2013-12-31 12.63 1.34 2.89
2013-09-30 12.63 1.34 2.89
2013-06-30 10.64 1.73 2.07
2013-03-31 10.64 1.73 2.07
2012-12-31 10.18 1.73 2.41
2012-09-30 10.18 1.73 2.41
2012-06-30 9.46 1.82 2.95
  • Azure Healthcare's level of debt (4.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (10.6% vs 4.4% today).
  • Debt is well covered by operating cash flow (545.5%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 8.7x coverage).
X
Financial health checks
We assess Azure Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Azure Healthcare has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Azure Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Azure Healthcare dividends.
If you bought A$2,000 of Azure Healthcare shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Azure Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Azure Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:AZV Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Oceania Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.7%
Australia Market Average Dividend Yield Market Cap Weighted Average of 417 Stocks 4.3%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.5%
Australia Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:AZV Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2009-10-01 0.000 0.000
2009-08-28 0.000 0.000
2009-04-27 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Azure Healthcare has not reported any payouts.
  • Unable to verify if Azure Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Azure Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Azure Healthcare has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Azure Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Azure Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Azure Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Azure Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Clayton Astles
COMPENSATION A$674,986
TENURE AS CEO 3.8 years
CEO Bio

Mr. Clayton Astles has been the Chief Executive Officer of Azure Healthcare Limited since July 31, 2015. Mr. Astles serves as the President of Azure Healthcare's main operating subsidiary Austco. He has helped build the group's reputation as a leader in the nurse call and clinical software solutions market in the United States and has been instrumental in the establishment of a Software Development Centre and manufacturing facility in Dallas, which is responsible for developing the Austco's next generation products. Mr. Astles has worked with Azure for the last 7 years. Mr. Astles has been Executive Director at Azure Healthcare Limited since July 31, 2015. Mr. Astles, who has over 12 years leadership experience in the healthcare technology industry and joined Austco in April 2008 as Sales Manager and held the positions of Vice-President and President of Austco's Canadian business. Since his arrival he has led a successful direct sales and channel sales organisation across North America. He holds a diploma in Electronics Engineering.

CEO Compensation
  • Clayton's compensation has been consistent with company performance over the past year.
  • Clayton's remuneration is higher than average for companies of similar size in Australia.
Management Team Tenure

Average tenure of the Azure Healthcare management team in years:

0.5
Average Tenure
  • The average tenure for the Azure Healthcare management team is less than 2 years, this suggests a new team.
Management Team

Clayton Astles

TITLE
CEO & Executive Director
COMPENSATION
A$675K
TENURE
3.8 yrs

Jason D'Arcy

TITLE
Executive Officer
COMPENSATION
A$450K
AGE
49
TENURE
0.5 yrs

Michael Read

TITLE
General Manager of Australasia
COMPENSATION
A$248K

Brendan Maher

TITLE
CFO & Company Secretary
AGE
50
TENURE
0.5 yrs
Board of Directors Tenure

Average tenure of the Azure Healthcare board of directors in years:

3.5
Average Tenure
  • The tenure for the Azure Healthcare board of directors is about average.
Board of Directors

Graeme Billings

TITLE
Independent Non-Executive Chairman
COMPENSATION
A$85K
AGE
62
TENURE
3.5 yrs

Clayton Astles

TITLE
CEO & Executive Director
COMPENSATION
A$675K
TENURE
3.8 yrs

Brett Burns

TITLE
Independent Non-Executive Director
COMPENSATION
A$70K
TENURE
3.5 yrs

Tony Glenning

TITLE
Independent Non-Executive Director
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Azure Healthcare insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
17. Apr 19 Buy Clayton Astles Individual 12. Apr 19 12. Apr 19 363 A$0.06 A$23
08. Apr 19 Buy Clayton Astles Individual 03. Apr 19 04. Apr 19 298,364 A$0.06 A$19,307
19. Dec 18 Buy Anthony Glenning Individual 17. Dec 18 17. Dec 18 400,000 A$0.07 A$26,400
X
Management checks
We assess Azure Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Azure Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Kind Of Shareholders Own Azure Healthcare Limited (ASX:AZV)?

Every investor in Azure Healthcare Limited (ASX:AZV) should be aware of the most powerful shareholder groups. … Taking a look at our data on the ownership groups (below), it's seems that. … View our latest analysis for Azure Healthcare

Simply Wall St -

Is Azure Healthcare Limited (ASX:AZV) A Volatile Stock?

If you're interested in Azure Healthcare Limited (ASX:AZV), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Simply Wall St -

Here’s What Azure Healthcare Limited’s (ASX:AZV) Return On Capital Can Tell Us

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Return On Capital Employed (ROCE): What is it? … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Is Azure Healthcare Limited (ASX:AZV) Overpaying Its CEO?

Clayton Astles has been the CEO of Azure Healthcare Limited (ASX:AZV) since 2015. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Clayton Astles's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Can We See Significant Insider Ownership On The Azure Healthcare Limited (ASX:AZV) Share Register?

If you want to know who really controls Azure Healthcare Limited (ASX:AZV), then you'll have to look at the makeup of its share registry. … With a market capitalization of AU$15m, Azure Healthcare is a small cap stock, so it might not be well known by many institutional investors. … View our latest analysis for Azure Healthcare

Simply Wall St -

Does Azure Healthcare Limited (ASX:AZV) Have A Volatile Share Price?

If you're interested in Azure Healthcare Limited (ASX:AZV), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

Boasting A 12% Return On Equity, Is Azure Healthcare Limited (ASX:AZV) A Top Quality Stock?

By way of learning-by-doing, we'll look at ROE to gain a better understanding Azure Healthcare Limited (ASX:AZV). … Our data shows Azure Healthcare has a return on equity of 12% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Why Azure Healthcare Limited's (ASX:AZV) Ownership Structure Is Important

In this article, I'm going to take a look at Azure Healthcare Limited’s (ASX:AZV) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. … ASX:AZV Ownership Summary August 22nd 18

Simply Wall St -

Azure Healthcare Limited (ASX:AZV): Time For A Financial Health Check

Investors are always looking for growth in small-cap stocks like Azure Healthcare Limited (ASX:AZV), with a market cap of AU$14.43m. … However, an important fact which most ignore is: how financially healthy is the business?

Simply Wall St -

Does Azure Healthcare Limited's (ASX:AZV) Recent Track Record Look Strong?

In this article, I will take a look at Azure Healthcare Limited's (ASX:AZV) most recent earnings update (31 December 2017) and compare these latest figures against its performance over the past few years, along with how the rest of AZV's industry performed. … How AZV fared against its long-term earnings performance and its industry … AZV is loss-making, with the most recent trailing twelve-month earnings of -AU$1.42m (from 31 December 2017), which compared to last year has become

Simply Wall St -

Company Info

Description

Azure Healthcare Limited, together with its subsidiaries, manufactures, services, supplies, and distributes healthcare and electronic communications equipment in Australia, New Zealand, Asia, Europe, and North America. It offers Tacera, a nurse call and healthcare communication system for hospitals and aged care facilities; MediCom, a nurse call system for use in hospitals and nursing homes; and CellGuard that provides audio communication solution, including officer duress, cell intercom, discrete monitoring, door intercom, background music distribution, and public address announcements. The company was formerly known as TSV Holdings Limited and changed its name to Azure Healthcare Limited in January 2012. Azure Healthcare Limited is headquartered in Port Melbourne, Australia.

Details
Name: Azure Healthcare Limited
AZV
Exchange: ASX
Founded:
A$16,289,897
232,712,826
Website: http://azurehealthcare.com.au
Address: Azure Healthcare Limited
1/31 Sabre Drive,
Port Melbourne,
Victoria, 3207,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX AZV Ordinary Shares Australian Securities Exchange AU AUD 24. Sep 2004
CHIA AZV Ordinary Shares Chi-X Australia AU AUD 24. Sep 2004
Number of employees
Current staff
Staff numbers
102
Azure Healthcare employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/23 10:30
End of day share price update: 2019/04/23 00:00
Last earnings filing: 2019/02/26
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.